GENEART AG and Applied Biosystems Deutschland GmbH intend to conclude a domination agreement

11-Jun-2010 - Germany

GENEART AG and its majority shareholder, Applied Biosystems Deutschland GmbH, intend to conclude a domination agreement pursuant to Section 291 et seq. German Stock Corporation Act (Aktiengesetz) with GENEART AG as the dominated entity and Applied Biosystems Deutschland GmbH as the dominating entity. GENEART AG and Applied Biosystems Deutschland GmbH want to execute such agreement before GENEART AG's annual general meeting scheduled for August 19, 2010. The domination agreement shall be submitted for approval to GENEART AG's general meeting in the context of the company's annual general meeting scheduled for August 19, 2010.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances